Agilent TechnologiesA

NYSE · USA · Segment 5 of 8 in the Medicine, pharma & life science value chain: Life science tools

Laboratory analysis is the business: LC/MS and other analytical instruments, sold with the consumables and diagnostic reagents that keep them running.

Life science tools: Instruments, reagents and equipment for research, development and production.

Key metrics

Market cap

$41.5B

Price

$153.43

Today

−3.5%

Return YTD

+16.9%

Return 1Y

+35.7%

P/E

29.4

P/S

5.7

P/B

5.8

Data as of 2026-08-25 · updates daily after U.S. close

Theme exposure

Analytical instrumentsLife science toolsDiagnostics exposureDiagnostics

In the value chain

Products & services

Analytical instruments (LC/MS)
Laboratory consumables
Diagnostic reagents

Competitors

Thermo Fisher
Danaher
Waters

Risks

Cyclical demand
Exposure to the China market

Supply chain

Supplies →

AbbVieABBV PfizerPFE

Full supply chain for A →

Same segment: Life science tools

Thermo Fisher ScientificTMO DanaherDHR Waters CorporationWAT IlluminaILMN RevvityRVTY

Compare A

A vs TMO A vs DHR A vs WAT A vs ILMN A vs RVTY

See where Agilent Technologies sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →